Balancing the impact of socio-ethical and economic considerations on clinical-hospital decision-making Authors: Royi Barnea, Aviad Tur-Sinai, Orna Tal Published: 2026 ABSTRACT AbstractBackgroundHealthcare systems increasingly operate under chronic scarcity, requiring prioritisation decisions beyond formal coverage policies and bedside clinical judgment. While much of the ethical literature on priority setting has focused on macro-level allocation or individual clinician decision-making, comparatively limited attention has been devoted to the meso level, where senior hospital medical managers shape access through implicit operational decisions under sustained constraint.MethodsThis study examines how senior medical managers approach prioritisation when clinical need, prognosis, and expected benefit are held constant. Using structured allocation scenarios that vary only in socio-ethical and economic patient characteristics, we conceptually distinguish between the practical acceptability of non-clinical criteria and their perceived normative legitimacy. Eighty-two senior medical managers participate.ResultsMost respondents appear to reject explicit prioritisation under scarcity, endorsing equal treatment even when resources are insufficient. When prioritisation occurs, younger patients are more frequently favoured, typically on clinical rather than on economic grounds. Economic determinants, including reimbursement status, insurance coverage, and anticipated downstream costs, were rarely endorsed as explicit prioritization criteria despite participants’ simultaneous recognition of responsibility for departmental sustainability.ConclusionsThese findings suggest a structured moral tension at the meso level. Economic constraints may be reframed through clinically grounded justifications, potentially obscuring underlying value tradeoffs, while non-prioritisation itself emerges as an ethically meaningful stance with distributive consequences. Using acceptability and legitimacy as a conceptual lens, this study underscores the need for transparent, procedurally robust approaches to hospital-level prioritisation under chronic scarcity.Supplementary InformationThe online version contains supplementary material available at 10.1186/s12910-026-01502-7.Keywords: Resource allocation, Hospital prioritisation, Economic constraints, Equity and fairness, Decision legitimacy, Healthcare management, Ethical decision-making Background Healthcare systems increasingly operate under chronic scarcity, not as a temporary deviation from standard practice but as a persistent structural condition. Population aging, multimorbidity, costly technologies, workforce shortages, and rising expectations have widened the gap between need and capacity [1]. Under these conditions, rationing becomes embedded in everyday care delivery, often implicitly expressed in waiting times, sequencing decisions, or variation in intensity of services rather than explicit denial [2, 3]. As demand for admission and complex care continues to rise faster than feasible expansions in beds and staff, prioritization at the hospital level becomes unavoidable [4, 5]. Israel provides a salient setting for examining routine prioritization under sustained constraint. Despite universal coverage and strong population health indicators, the system operates under relatively low hospital bed supply, high occupancy rates, and limited slack [6, 7]. Alongside these pressures, Israel maintains a highly institutionalized national-priority–setting mechanism that explicitly allocates new technologies up to the limit of a fixed budget [8]. Macro-level prioritization, however, does not eliminate scarcity at point of delivery. Instead, it shifts allocation decisions to hospitals, where operational constraints, local budgets, and waiting lists affect who receives care first and intensively. Routine prioritization in hospitals occurs under enduring constraints and requires ongoing choices among patients whose clinical needs may be comparable but whose social circumstances, economic implications, or expected downstream resource use differ [9, 10]. These meso-level decisions are often made by senior medical managers, including department heads, clinical directors, and hospital executives, who operate between clinical obligations and institutional sustainability. Their position places them under distinct ethical tension: they are expected to uphold egalitarian norms while safeguarding access for all by ensuring the viability of services over time [11]. This is precisely where implicit value tradeoffs may emerge [12, 13]. Concurrently, the health-technology–assessment field has advanced deliberative multi-criteria approaches that integrate clinical effectiveness, cost and affordability, and broader social values through structured assessment and stakeholder deliberation [14, 15]. Much of the literature on these topics, however, focuses on macro priority-setting or bedside rationing; far less is known about how senior hospital medical managers weigh socio-ethical and economic considerations under conditions of routine scarcity, especially when clinical prognosis is held constant [16, 17]. A key conceptual distinction in this context concerns legitimacy and acceptability. Legitimacy denotes the normative justification of a criterion within widely endorsed ethical principles such as fairness, equity, or stewardship of limited resources. Acceptability reflects whether decision-makers perceive this criterion as appropriate or defensible in practice. These dimensions do not necessarily align. Criteria may be ethically defensible yet operationally resisted or widely accepted despite weak normative grounding. Conflating descriptive behavior with ethical endorsement risks obscuring this distinction. We therefore document which socio-ethical and economic considerations managers report being willing to incorporate under equal clinical need, using acceptability and legitimacy as a conceptual interpretive framework rather than measured constructs [15]. At the same time, the types of non-clinical considerations that may enter routine prioritization are not random. In practice, managers often confront tradeoffs linked to expected resource use over time, institutional affordability, and the broader social consequences of delayed care [18]. Economic considerations include short-term costs, length of stay, and downstream financial impact [19]. Socio-ethical considerations include vulnerability, caregiving responsibilities, socioeconomic disadvantages, and benefits beyond strictly clinical outcomes. Such multidimensional value tradeoffs are common under scarcity and are rarely captured by single-criterion approaches; this is why structured multi-criteria, and deliberative frameworks have been advocated to illuminate and justify these factors explicitly [16]. Empirical work on meso-level decision-making also demonstrates that local decision-makers struggle to operationalize ethical principles when non-clinical criteria, political pressures, and budget constraints intersect, making this level a likely site of moral tension [20]. Because these considerations touch on equity, social values, and institutional survival simultaneously, their legitimacy at the point of hospital allocation remains unclear and renders them worthy of direct empirical examination. Senior MMs play a hybrid role that combines clinical authority with organizational responsibility. Unlike frontline clinicians, they are accountable not only for individual patient outcomes but also for departmental performance, resource utilization, staffing stability, and long-term sustainability. Such hybrid positions are particularly prone to tension by demanding reconciliation of competing logics of care and efficiency under persistent constraint. These structural pressures make senior MMs a critical, yet understudied, group in empirical research on routine hospital-level prioritization [21]. Clarifying these meso-level preferences is increasingly important. As chronic scarcity becomes a stable reality in aging healthcare systems, managerial choices about access, sequencing, and intensity of care will shape distributional outcomes as much as will formal coverage decisions [18, 22]. By understanding which non-clinical criteria MMs state they would be willing to consider, and where these criteria generate friction or moral conflict, institutional policies, leadership training, and system-level guidance may be developed more effectively to prevent ad hoc rationing from amplifying inequities. The present study examines how senior MMs approach prioritization under routine scarcity. Using structured allocation scenarios that hold clinical prognosis constant while varying socio-ethical and economic characteristics, we aim to make implicit value tradeoffs observable at the meso level. In doing so, we extend priority-setting scholarships beyond macro rules and bedside rationing to the managerial echelon that increasingly shapes access in constrained health systems. Aim To indicate the attitudes of MMs to various settings that incorporate the economic perspective alongside clinical considerations and to identify friction points and ethical dilemmas. Methods The survey was distributed through the leadership structures of 24 Israeli general hospitals, which constituted the institutional recruitment frame. Because distribution was partly mediated through hospital leadership structures, the exact number of individual invitees cannot be determined and a conventional individual-level response rate cannot be calculated. A total of 82 senior medical managers completed the questionnaire. Participants were asked to consider prioritization decisions involving patients who differed in selected socio-ethical and economic characteristics under conditions of resource scarcity. The questionnaire was developed for the current study (The full questionnaire, including vignette descriptions and participant instructions, is provided in Supplementary Material ). Participants were instructed to assume clinical equivalence across cases. While this approach cannot fully prevent respondents from implicitly introducing clinical considerations, it is commonly used in vignette-based designs to reduce variability and focus attention on non-clinical attributes. The intention was not to eliminate clinical reasoning entirely, but to create a structured context in which socio-ethical and economic considerations could become more salient. All scenarios were explicitly constructed by a steering committee composed of physicians and health-economics researchers, such that patients’ descriptions were equivalent in terms of clinical urgency, prognosis, and expected benefit from the intervention. Participants were instructed to assume that, from a strict medical perspective, no patient had priority over another. The scenarios used routine managerial terminology familiar to senior hospital leaders, including reimbursement and resource-allocation concepts. Because these terms reflect standard operational language rather than specialized study-specific constructs, no separate technical briefing was provided beyond the written instructions. This design was intended to isolate the influence of non-clinical considerations, economic and socio-ethical principles on prioritization decisions. A 1–10 scoring scale (1 = least important, 10 = most important) was used to capture the relative weight that participants attributed to each determinant, allowing for differentiation among outright rejection, moderate consideration, and strong prioritization. The option of assigning equal priority to all patients was included to distinguish principled non-prioritization from selective allocation preferences. Seven types of theoretical patients were described (Table 1); they were classified by four economic determinants and three social determinants. Participants scored patient prioritization under scarcity, such as limited operating-room availability or allocation of a single ECMO machine. Participants could also choose not to prioritize any patient, making allocation of treatment options egalitarian. Two scales were used: the first to rate the weight of each patient prioritization regardless of the others (Table 1, Column 1 A), meaning rating, and the second, to declare the first patient to be chosen (or the single best caregiving option), reflecting ranking (Table 1, Column B). Table 1Scoring prioritization of theoretical patients by determinants (economic, social) and importance (high, middle, low), rating and rankingRating/rankingA. How do you score the relative importance of prioritizing each patient?(rating)B. If you can choose only one patient(ranking)Score(1–10)High (8–10)Middle (5–7)Low (1–4)% of participants choosing this optionDeterminantsEconomic determinantsA DRG-based highly refundable patient18.18(n = 14)28.57(n = 22)53.25(n = 41)3.85%(n = 1)A patient with high expenses on imaging, laboratory tests, and consultations12.82(n = 10)34.62(n = 27)52.56(n = 41)3.85%(n = 1)An uninsured patient12.82(n = 10)30.77(n = 24)56.41(n = 44)0(n = 0)A patient requiring additional funding for longitudinal surveillance or rehabilitation17.95(n = 14)35.90(n = 30)46.15(n = 34)3.85%(n = 1)Social determinantsA young patient (aged 25–44 years)48.10(n = 38)25.32(n = 20)26.58(n = 21)80.77%(n = 21)An elderly patient) aged65 years and over(28.21(n = 22)33.33(n = 26)38.46(n = 30)3.85%(n = 1)A patient with no supportive family20.78(n = 16)37.66(n = 29)41.56(n = 32)3.85%(n = 1)Total100%Clinical concerns onlyAll patients share the same clinical prioritization61.04(n = 47)19.48(n = 15)19.48(n = 15)100% Scoring prioritization of theoretical patients by determinants (economic, social) and importance (high, middle, low), rating and ranking Score (1–10) 18.18 (n = 14) 28.57 (n = 22) 53.25 (n = 41) 3.85% (n = 1) 12.82 (n = 10) 34.62 (n = 27) 52.56 (n = 41) 3.85% (n = 1) 12.82 (n = 10) 30.77 (n = 24) 56.41 (n = 44) 0 (n = 0) 17.95 (n = 14) 35.90 (n = 30) 46.15 (n = 34) 3.85% (n = 1) 48.10 (n = 38) 25.32 (n = 20) 26.58 (n = 21) 80.77% (n = 21) 28.21 (n = 22) 33.33 (n = 26) 38.46 (n = 30) 3.85% (n = 1) 20.78 (n = 16) 37.66 (n = 29) 41.56 (n = 32) 3.85% (n = 1) 61.04 (n = 47) 19.48 (n = 15) 19.48 (n = 15) In Phase 2, participants evaluated leadership characteristics considered relevant to allocation-related decision-making. Here, the participants were asked to score on the 1–10 scale the perceived importance of 11 characteristics of leadership that departmental managers are expected to possess. The 11 managerial characteristics were derived through an iterative process combining insights from the literature on clinical leadership and input from the study steering committee. These variables were included as exploratory descriptors to characterize managerial orientations rather than as primary explanatory variables. Accordingly, these characteristics should be understood as broad and partly related domains of managerial orientation rather than as mutually exclusive psychometric dimensions. Informed consent to participate was obtained from all the participants in the study. The full questionnaire, including vignette descriptions and participant instructions, is provided in Supplementary Material. Results Eighty-two senior MMs responded to the survey. Of them, 61% refrained from prioritizing, declaring that all patients should be treated equally, whereas about 40% declared they would consider allocating treatment resources. Analyzing social determinants, we found that 48.1% of the respondents declared they would highly prioritize a young patient, 28.2% would prioritize the elderly, and 20.8% would highly prioritize a patient who has no supportive family. However, in assessing the median score, 25.32% preferred young patients, 33.33% older patients, and 37.66% patients with no family support. A similar perspective was attested in low prioritization: 26.58%, 38.46%, and 41.56% of young, old, and lone patients, respectively. Economic determinants had limited influence: 18.2% highly prioritized either a highly reimbursed patient or a patient requiring additional follow-up or rehabilitation resources. Only 12% declared they would highly prioritize an uninsured (undefendable) patient. A similar pattern was observed for low/dis-prioritization: (53%, 53%, 57%, and 46% respectively, for highly refundable patients, patients with primarily expected high expenses (for imaging, laboratory tests, and consultations), underinsured patients or patients who require longitudinal surveillance or rehabilitation. Intermediate importance was scored at 28.57%, 34.62%, 30.77%, and 35.9%, respectively (Table 1A). When asked to rank theoretical patients or choose an allocation for a single patient, 80.77% of participants chose the young patient. We further explored associations between prioritization scores and managerial characteristics. We analyzed 11 leadership characteristics, grouped into high, intermediate, and low importance. We found that the participants placed particularly high importance on formal managerial responsibility, accountability, and clinical role modeling,, managing performance and clinical handling (scored as highly important by 98.8% of participants), coordinating team assignments (96.3%), adjusting to local circumstances (agile management) (95%), and familiarity with Ethical awareness in organizational decision-making to tackle dilemmas intelligently (93.9%). Our participants scored as slightly less important the desire to establish a trustful relationship with the patient (89%) and family (87.8%) alongside being an educator and mentor (86.59%). Managing interpersonal conflicts and economic sustainability were characteristics of lower importance (82.9% each), as was leading research (67%). When we specifically observed characteristics that were scored extremely important (10 on a 1–10 scale), we grouped four themes: (a) supervising case management and being a role model (78.05%), tackling ethical dilemmas and culture (58.54%) as against education skills (37.8%), (b) building trust with the patient (56.1%) and family (51.2%), (c) sustaining economic balance (36.6%), and (d) guiding research (12.2%). A mirror image was attested in intermediate scores for clinical professionalism, managing conflicts, patient trust, family encounter, and economic sustainability: 13.41%, 15.85%, 10.97%, 9.76%, 10.98%, and 14.63%, respectively. Some 29.27% found middling importance in research abilities. A few participants gave this characteristic a score of low importance (Table 2). Table 2Selective role-model leadership characteristics of the medical managerCharacteristicsHigh (8–10)Medium (5–7)Low (1–4)Holding formal and managerial responsibility and accountability as a role model98.78(n = 81)1.22(n = 1)0(n = 0)Coordinating team assignments96.34(n = 79)3.66(n = 3)0(n = 0)Clinical professionalism85.37(n = 69)13.41(n = 11)1.22(n = 2)Ethical awareness in organizational decision-making93.90(n = 77)6.10(n = 5)0(n = 0)Adjusting to local circumstances95.12(n = 78)4.88(n = 4)0(n = 0)Managing conflicts while maintaining organizational performance82.93(n = 68)15.85(n = 13)1.22(n = 1)Research abilities67.07(n = 55)29.27(n = 24)3.66(n = 3)Education and mentorship86.59(n = 71)10.97(n = 9)2.44(n = 2)Explanatory dialogue with the patient89.02(n = 73)9.76(n = 8)1.22(n = 1)Dialogue with family members87.80(n = 72)10.98(n = 9)1.22(n = 1)Efficiency and economic sustainability82.93(n = 68)14.63(n = 12)2.44(n = 2) Selective role-model leadership characteristics of the medical manager 98.78 (n = 81) 1.22 (n = 1) 0 (n = 0) 96.34 (n = 79) 3.66 (n = 3) 0 (n = 0) 85.37 (n = 69) 13.41 (n = 11) 1.22 (n = 2) 93.90 (n = 77) 6.10 (n = 5) 0 (n = 0) 95.12 (n = 78) 4.88 (n = 4) 0 (n = 0) 82.93 (n = 68) 15.85 (n = 13) 1.22 (n = 1) 67.07 (n = 55) 29.27 (n = 24) 3.66 (n = 3) 86.59 (n = 71) 10.97 (n = 9) 2.44 (n = 2) 89.02 (n = 73) 9.76 (n = 8) 1.22 (n = 1) 87.80 (n = 72) 10.98 (n = 9) 1.22 (n = 1) 82.93 (n = 68) 14.63 (n = 12) 2.44 (n = 2) A similar overall pattern was observed among participants who rejected prioritization altogether: supervising case management as a role model was scored extremely important by 88.46%, meeting ethical dilemmas and culture (57.69%) versus education skills (40.38%); (b) building trust with the patient (61.54%) and family (53.85%); (c) sustaining economic balance (40.38%); and (d) guiding research (15.38%). We specifically observed scoring of role-model leadership characteristics as extremely important (10 on a 1–10 scale) by our participants, comparing the scores of the entire sample population and the group of MMs who avoided prioritization (n = 52; 60% of respondents; Table 3). Interestingly, managers who avoided prioritization scored almost every characteristic higher, especially holding formal and managerial responsibility and accountability as a role model (88% and 78%, respectively), coordinating team assignments (61.5%, 50%), and clinical professionalism (26.8, 32.7), and to a lesser degree other characteristics: adjusting to local circumstances, research abilities, education and mentorship, explanatory dialogue with the patient and family, and efficiency and economic sustainability, with the exception of managing conflicts while maintaining organizational performance. Surprisingly, managers who renounced prioritization scored ethical awareness in organizational decision-making much as the entire population of respondents. Table 3Highly important characteristics of role-model leadership of the medical manager, comparing the number and percentage of responders from the entire sample and MMs who avoided prioritizationCharacteristicsAll participants (%, (n))Managers who avoided prioritization (%, (n))Holding formal and managerial responsibility and accountability as a role model78.05(n = 64)88.46(n = 46)Coordinating team assignments50.00(n = 41)61.54(n = 32)Clinical professionalism26.83(n = 22)32.69(n = 17)Ethical awareness in organizational decision-making58.54(n = 48)57.69(n = 30)Adjusting to local circumstances47.56(n = 39)50.00(n = 26)Managing conflicts while maintaining organizational performance25.61(n = 21)23.08(n = 12)Research abilities12.20(n = 10)15.38(n = 8)Education and mentorship37.80(n = 31)40.38(n = 21)Explanatory dialogue with the patient56.10(n = 46)61.54(n = 32)Dialogue with family members51.22(n = 42)53.85(n = 28)Efficiency and economic sustainability36.59(n = 30)40.38(n = 21)Total number of responders8252 Highly important characteristics of role-model leadership of the medical manager, comparing the number and percentage of responders from the entire sample and MMs who avoided prioritization 78.05 (n = 64) 88.46 (n = 46) 50.00 (n = 41) 61.54 (n = 32) 26.83 (n = 22) 32.69 (n = 17) 58.54 (n = 48) 57.69 (n = 30) 47.56 (n = 39) 50.00 (n = 26) 25.61 (n = 21) 23.08 (n = 12) 12.20 (n = 10) 15.38 (n = 8) 37.80 (n = 31) 40.38 (n = 21) 56.10 (n = 46) 61.54 (n = 32) 51.22 (n = 42) 53.85 (n = 28) 36.59 (n = 30) 40.38 (n = 21) Discussion Meso-level healthcare decision-making is shaped not only by individual judgment but also by organizational culture, structural constraints, and institutional logics. Prior work in organizational ethics suggests that decision-makers operate within embedded norms and practices that shape what is perceived as appropriate, legitimate, or even visible as a decision factor. In this sense, managerial prioritization is not merely a reflection of individual ethical preferences, but also of the organizational environment in which these decisions are made, including performance pressures, accountability structures, and implicit professional norms. Our findings fit this perspective, reflecting possible interactions between individual reasoning and institutional context. Hospital decision-making has traditionally been framed primarily in clinical and professional terms. However, under conditions of chronic scarcity, senior managers are increasingly required to engage with organizational and economic constraints that are not easily incorporated into conventional clinical reasoning. The tension between these two expectations may help explain both the reluctance to prioritize explicitly and the tendency to justify difficult choices in clinically acceptable language. In practice, senior medical managers face layered decisions. They must protect patients’ welfare and clinical standards while considering capacity, staffing, financial sustainability, waiting times, and fairness [23, 24]. This combination of responsibilities helps explain why meso-level prioritization may generate both ethical tension and reluctance to rely explicitly on non-clinical criteria. At the same time, while this pattern may reflect discomfort in engaging with non-clinical trade-offs, preparedness was not directly measured in the present study. This interpretation should therefore be treated as a hypothesis for future research rather than as an empirical finding. Our findings show how managers may navigate the boundary between clinical and economic stewardship. By examining how non-clinical considerations are acknowledged, reframed, or rejected, this study helps clarify how scarcity may shape distributive outcomes at the hospital level. Over 60% of MMs refrained from prioritization. While this may reflect discomfort or perceived lack of preparedness in engaging with non-clinical tradeoffs, this interpretation should be treated with caution, as preparedness was not directly measured in the study. Such egalitarian responses may reflect a normative commitment to equality rather than an operational strategy for managing scarcity. These findings highlight the need to address clinical-ethical dilemmas created by scarcity, including the burden of balancing patient needs with institutional sustainability [25]. Across our scenarios, participants frequently framed allocation decisions in explicitly clinical terms even when the underlying constraint was economic. This pattern may be consistent with concerns that rationing can be obscured when presented as a purely medical judgment call [26]. This tendency echoes the argument that value judgments in allocation are sometimes concealed, possibly undermining perceptions of accountability and procedural defensibility unless explicit tradeoffs are made [26]. Participants’ reluctance to cite cost, alongside clinical justifications, may suggest that economic constraints are reframed in clinically acceptable terms. This may help organizations cope but may weaken transparency and public defensibility [26]. The apparent rejection of prioritization under scarcity warrants attention. While this stance may reflect the assignment of equal importance to equality and professional norms, it is an active managerial position with distributive consequences. Under constraint, refusal to prioritize may shift allocation into less visible mechanisms, such as waiting times or informal sequencing. Other explicit approaches, such as lotteries, are also possible. The possibility of this outcome resonates with concern that indirect or hidden rationing will undermine accountability when tradeoffs are not explicitly acknowledged [26]. Non-prioritization should therefore be understood not as neutrality but as a meaningful ethical stance that shapes the way scarcity is managed in practice at the hospital level. Several patterns in our results also align with empirical work suggesting that prioritization is shaped not only by ethical frameworks but also by institutional contexts and governance constraints. A recent study demonstrated how reforms, accountability gaps, and austerity conditions may curtail the operationalization of procedural ideals (including transparency) even when decision-makers recognize them as important [20]. Our findings resonate with this “ideal versus real” gap at the hospital level: participants appear to recognize the normative attraction of fairness and clinical need yet operate in a constrained environment where financial sustainability is an unavoidable condition of continued service provision. This may help explain why, in our vignettes, prioritization may be described by participants in clinically grounded terms, while also being shaped by broader organizational constraints, although this interpretation cannot be directly confirmed by the present design. Age-related prioritization should be interpreted as an observed response pattern rather than as evidence of respondents’ underlying reasoning. Younger patients were more frequently prioritized in both rating and forced-choice tasks. However, we did not collect qualitative explanations that would clarify whether age reflected prognosis, social value, or broader fairness intuitions. This uncertainty is therefore acknowledged as part of the study’s interpretive limits. Age-related response patterns were among the clearest differences observed in our data. Compared with other patient characteristics, younger age was more frequently associated with prioritization in both rating and forced-choice responses. However, participants’ explanations for this tendency appeared to rely more on clinical reasoning, such as expected prognosis or anticipated benefit, rather than explicit economic considerations. This pattern should be interpreted with caution, as the study design does not allow us to determine whether age functioned as a social value, a proxy for clinical expectations, or a broader moral intuition regarding fairness across the life course. A recent longitudinal survey of public preferences in scarce-medical–resource allocation between patients in different age cohorts found substantial support for prioritizing younger patients alongside favoring of equal priority or older patients by sizable minorities [27]. Public views do not settle the moral question. They do, however, help characterize the moral landscape in which institutional policies must be justified. This is closely aligned with recent work in the priority-setting ethics literature that argues empirical studies of public values can play multiple roles in justificatory reasoning, including identifying points of convergence, contestation, and the likely acceptability of candidate principles [28]. Similar findings were uncovered in a previous study that was conducted by our team [29], with significant prioritization of the elderly expressed by the Arab population, possibly reflecting culturally embedded attitudes toward age-related prioritization within parts of Israeli society. Lower prioritization of the uninsured was expressed, perhaps due to the publicly funded, high-coverage nature of the Israeli healthcare system. A different approach was observed in dealing with economic matters. Fewer than 20% of participants endorsed economic determinants. More than half rated them as low importance. For example, highly refundable patients (53.25%), or the opposite, patients who require additional resources, such as those who incur high expenses on imaging, laboratory tests, and consultations (52.56%) scored similar to uninsured patients (56.4%) and those requiring additional funding for longitudinal surveillance or rehabilitation (46%). That is, revenue considerations did not appear to function as explicit guiding principles in participants stated responses. Continuing, economic determinants were largely rejected as explicit criteria for prioritization. Few participants endorsed preferential treatment for highly refundable patients, uninsured patients, or those expected to generate higher downstream costs. Yet managers simultaneously emphasized their responsibility for performance and sustainability. This tension may reflect a broader feature of health systems, in which economic incentives, institutional responsibilities, and the time horizons of different decision-makers are not always fully aligned. In such contexts, cost-related considerations may remain salient at the organizational level while still being difficult to articulate as legitimate criteria in case-based prioritization decisions. This may protect professional identity but may also obscure value tradeoffs that continue to influence access indirectly [26]. The ethical challenge, therefore, is not simply whether cost should count but how economic stewardship can be acknowledged transparently without reducing patients to financial variables. Beyond the importance of a trustful patient-doctor relationship, our participants emphasized the leadership characteristics that senior managers at the hospital level should possess being a role model for clinical decision-making including dealing with ethical dilemmas and paving the way for junior staff members via comprehensive education and mentoring. These topics transcend academic research in a highly overloaded and stressful environment. Viewed broadly, these findings suggest a gradient of responsibility: individual accountability, professional accountability toward patients and families, and mentorship within the team and organization. Our findings have important implications for the ethical frameworks that govern routine prioritization in hospitals. Much of the priority-setting literature emphasizes the legitimacy of criteria such as cost-effectiveness, severity, and benefit, yet our findings may be interpreted as consistent with the possibility that, at the meso level, perceptions of legitimacy may depend less on agreement about specific criteria and more on confidence in the moral defensibility of the decision-making process itself. This observation aligns with recent work published in the Journal of Medical Ethics that procedural approaches may be insufficient on their own and that coherence-based accounts (such as narrow reflective equilibrium) may function as a complementary source of moral justification in priority-setting contexts [30]. The ethical challenge is not only whether age or cost should count. It is how managers can be supported to make and justify decisions that are publicly defensible, professionally sustainable, and aligned with institutional values [28–30]. Our findings may be interpreted through the conceptual distinction between acceptability and legitimacy, particularly in situations where managers appear willing to endorse certain allocation practices operationally while remaining hesitant to frame them as normatively justified. This study aims to contribute to empirical bioethics by showing how descriptive findings can inform, but not replace, ethical evaluation. While the study is situated in the Israeli healthcare system, similar structural pressures exist in other health systems, suggesting that the observed patterns may have broader relevance, although contextual differences should be considered. From a practical perspective, such decision-support frameworks could take several forms. These may include structured deliberation tools that explicitly require consideration of clinical, economic, and social criteria; institutional guidelines that define acceptable boundaries for non-clinical prioritization; and multidisciplinary committees that provide shared accountability for complex allocation decisions. In addition, training programs for senior managers could incorporate ethical reflection on real-world allocation dilemmas, helping to bridge the gap between normative principles and operational decision-making. Importantly, these frameworks are not intended to prescribe uniform decisions, but rather to promote transparency, consistency, and ethical defensibility in contexts where trade-offs are unavoidable. Conclusions The findings suggest that senior medical managers recognize the tension between clinical and economic stewardship, but the present study does not directly assess preparedness or managerial competence. Rather, the results point to a need for clearer institutional guidance and structured support when non-clinical trade-offs arise under conditions of scarcity. This study suggests that MMs are willing to consider a broader perspective on care, provided they are supported by explicit guidelines and clear institutional policy. Nevertheless, a strictly economic approach to supervising medical decisions must be wisely addressed. The findings suggest that routine prioritization under chronic scarcity cannot rely solely on individual moral reasoning or informal professional norms. Institutional responses should therefore focus on structured decision-support frameworks, targeted leadership training, and explicit procedural guidance that acknowledge the existence and ethical salience of meso-level tradeoffs, while setting clear boundaries on the use of non-clinical criteria. Such frameworks need not mandate prioritization but should provide a common language, ethical reference points, and organizational backing for managers who have to make difficult allocation decisions. Making value considerations explicit may reduce moral distress among senior clinicians. It may also improve transparency and consistency in access decisions. Careful and thorough preparedness should be considered to avoid a slippery slope that may jeopardize optimal care. Limitations This study has several limitations. First, although we approached the national leadership echelon of senior public hospital managers, the sample size remains modest. Selection or non-response bias may limit generalizability beyond the participants. Second, the vignette-based design, while useful for holding clinical factors constant, does not fully capture the complexity of real-world allocation decisions and respondents may have implicitly reintroduced clinical considerations when reasoning about age, for example. Third, we measured stated preferences rather than observed behavior; reported reluctance to use economic criteria may differ from how prioritization occurs indirectly through operational mechanisms such as scheduling or waiting times. Furthermore, the explicit framing of the task as a prioritization exercise may have increased susceptibility to social desirability bias. Participants’ reluctance to prioritize or to endorse economic criteria may therefore reflect normative positioning rather than actual decision-making tendencies. These patterns may also be interpreted in light of organizational perspectives suggesting that institutional norms and constraints can shape decision-making in ways that are not always fully visible to decision-makers themselves. In addition, the vignette-based design relies on participants’ adherence to the assumption of clinical equivalence. Respondents may reconstruct clinical differences when such information is limited. This introduces uncertainty regarding the extent to which observed preferences reflect purely non-clinical considerations. We recognize that limiting clinical detail is not equivalent to fully controlling respondents’ clinical assumptions. Rather, this design was intended to reduce case-specific clinical variability and to foreground non-clinical considerations within familiar managerial scenarios. Despite these limitations, the design isolated non-clinical determinants under assumptions of equal clinical need. This made otherwise implicit value tradeoffs more observable at the meso level. The consistency of patterns across rating and forced-choice tasks supports the robustness of the findings and provides a credible empirical basis for further normative analysis and the development of procedural guidance for ethically defensible prioritization under conditions of routine scarcity. Supplementary Information Supplementary Material 1 Acknowledgements Not applicable. Authors’ contributions RB conceived the study idea, contributed to the development of the research framework, participated in drafting the manuscript, and validated the research instruments.ATS contributed to the study conception and design, took part in writing and refining the manuscript, validated the research tools, and led the data analysis.OT contributed to the conceptualization of the study, co-developed the research design, led writing and revising the manuscript, validated the research tools, and was responsible for data collection. Funding Not applicable. Data availability The datasets generated and/or analyzed during the current study are not publicly available due privacy restrictions but are available from the corresponding author on reasonable request. Declarations Ethics approval and consent to participate The study adhered to the Declaration of Helsinki and was approved by the Shamir Medical Center (Assaf Harofeh (IRB committee, approval number 0072-24-ASF. Informed consent to participate was obtained from all of the participants in the study. Consent for publication Not applicable. Competing interests The authors declare no competing interests. Footnotes Publisher’s Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Supplementary Materials Supplementary Material 1 Data Availability Statement The datasets generated and/or analyzed during the current study are not publicly available due privacy restrictions but are available from the corresponding author on reasonable request.